Skip to main content
. 2020 Nov 20;55(1):1–11. doi: 10.1097/MCG.0000000000001459

TABLE 3.

WGO Recommendations Regarding the General Approach to Patients With Liver Disease in the Era of COVID-19

In this COVID-19 era, routine outpatient testing of liver biochemistry is not recommended In patients with elevated ALT or AST, rule out viral hepatitis. This may be particularly important in developing countries, as patients may not have been tested before Routine investigation to exclude other etiologies should take into consideration local context and availability Routine imaging is not recommended unless it will alter management

ALT indicates alanine aminotransferase; AST, aspartate aminotransferase.